|
|
| |
|
WHY IS IT VALUABLE TO ATTEND?
|
| |
|
|
| |
|
|
|
|
|
|
|
|
| |
 |
| |
Download the full Programme and focus on
the scientific sessions fil rouge:
TREATABLE TRAITS: a look forward
★ AIRFLOW LIMITATIONS
★ EOSINOPHILIC AIRWAY INFLAMMATION
★ CHRONIC BRONCHITIS
★ AIRWAY BACTERIAL COLONISATION
★ BRONCHIECTASIS
★ INTERSTITIAL LUNG DISEASES |
The keynote lectures:
|
| |
|
|
| |
|
|
|
|
Treatable Traits: toward precision medicine of airway diseases |
| |
|
| Anneke ten Brinke (The Netherlands) |
| |
|
|
|
| |
|
| |
|
|
|
|
Dupilumab and T2 Inflammation: the common driver of asthma and
nasal polyposis
|
| |
|
| G. Walter Canonica (Italy) |
| |
|
|
|
| |
|
| |
|
|
|
|
Airway Mycobacteria Management |
| |
|
|
|
|
|
| |
|
| |
|
|
|
|
Alpha1 Antirtypsin and Neutrophil Elastasis: A challenge between giants |
| |
|
|
|
|
|
| |
|
| |
|
|
|
|
Can we use the Treatable Traits concept to improve clinical practice? |
| |
|
|
|
|
|
| |
|
| |
|
|
|
|
|
|
| |
|
Benefit of the Early Registration Fee
|
| |
|
| |
|
|
|
| |
|
|
|
|
|
|
| |
|
CONGRESS PRESIDENTS AND CHAIRMEN
|
| |
|
|
| |
|
|
| |
 |
| |
|
From left to right: Francesco Blasi, G. Walter Canonica, Stefano Aliberti, Johann Christian Virchow, Stefano Centanni, Tobias Welte
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |
ORGANISING SECRETARIAT
Address: 74 Boulevard d’Italie, 98000 MONACO
Phone number: + 377 97 97 35 55
Fax number: + 377 97 97 35 50
E-mail: info@lung-health.org |
| |
|
| |
|
|
|
|
|
|
|
